“Tumor Ablation Industry” is anticipated to witness CAGR of over 11.1% over the next seven years. The market is expected to witness considerable growth in demand owing to the advent of technology and innovation in the area of thermal ablation.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Market growth is expected to be primarily influenced by increasing the prevalence of cancer. As per World Health Organization, approximately 13.0% of the deaths that happen globally occur due to cancer. Major market drivers include cancer prevalence and ‘thermal ablation’ innovations. In fact, multiple cancer incidences positively affect market expansion. Over 100 cancers affect people globally. These need distinctive treatments, thus propelling market incomes.

Increasing elderly populace may also boost market growth. Demand for minimally invasive surgeries has augmented. This has led to quicker recovery & lower trauma for patients. Radiofrequency ablation procedures involve minimal invasiveness. Their escalating demand is also predicted to drive the tumor ablation market till 2022.

Access Detail Report with TOC @
http://www.hexareports.com/report/tumor-ablation-market-analysis/details

The market is categorized as per technologies, treatments, applications, and regions. Technologies are cryoablation, microwave, radiofrequency, and others. ‘Others’ comprises laser ablation, High-Intensity Focused Ultrasound (HIFU), radioiodine, etc. Radiofrequency was the dominant segment in 2015. Microwave is said to experience lucrative expansion in the near future. Its better efficiency coupled with least complications & process time should spur the segment.

Treatments are percutaneous, laparoscopic, and surgical. Surgical dominated the market in 2015. On the other hand, percutaneous will grow significantly from 2015 to 2022. This could be ascribed to wider demand for minimally invasive procedures. Applications of the tumor ablation market encompass various cancers.

These cancers affect the prostate, liver, lungs, head & neck, ENT (ears, nose, & throat), breasts, kidneys, and other parts. Liver cancer led the market in 2015. It may grow further during the forecast period. However, lungs are projected to experience significant growth in the near future. The same would be credited to smoking, air pollution, and inactive lifestyles.

Related “Medical Devices” Market Research Reports:

Global Gamma Camera Industry 2016
http://www.hexareports.com/report/global-gamma-camera-industry-2016/details

Global Medical Computer Carts Market
http://www.hexareports.com/report/global-medical-computer-carts-market-forecast-and-analysis-2016-2021/details

Regions wise, the market is split into Asia-Pacific (APAC), the Middle East & Africa, Europe, Latin America, and North America. North America dominated the market in 2015. APAC should record the fastest CAGR in the coming seven years. This can owe to its improved medical infrastructure. Players of APAC are likely to benefit from financial expansions and huge populace in the region.

Key companies in the global tumor ablation market consist of Boston Scientific Corporation, HealthTronics, SonaCare Medical, and Neuwave Medical Inc. They attempt at working their way to the top through acquisitions, mergers, partnerships, product developments, and other innovations.

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Info:
Name: Ryan Shaw
Organization: Hexa Research
United States
Phone: +1-800-489-3075

For more information, please visit http://www.hexareports.com/report/tumor-ablation-market-analysis/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/tumor-ablation-market-is-estimated-to-grow-at-a-healthy-cagr-during-the-forecast-period-to-2022-hexa-reports/121224

Release ID: 121224

Obesity is a major growing health concern around the world. In most markets, a person is considered obese if their Body Mass Index (BMI) exceeds 30 kilograms per square meter (kg/m2), calculated by dividing body mass in kilograms by height in meters squared.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Frontier Pharma: Obesity – Identifying and Commercializing First-in-Class Innovation with the global prevalence continuing to rise, the disease has placed significant burden on healthcare expenditure, as it is also a major risk factor for cardiovascular diseases, diabetes and cancer.

Anti-obesity pharmacotherapy can be used as an adjunct lifestyle modification to improve weight loss in order to significantly reduce obesity-associated health risks in obese patients. However, the use of currently available anti-obesity drugs is largely limited by poor long-term safety and a modest weight loss effect. Despite substantial clinical and regulatory challenges, the early-stage obesity pipeline remains robust, containing a high level of first-in-class innovation that has the potential to be translated into effective and safe weight loss treatments.

Browse Detail Report with TOC @
http://www.hexareports.com/report/frontier-pharma-obesity-identifying-and-commercializing-first-in-class-innovation/details

Scope

Historically, the obesity market has suffered from long-term safety concerns and modest efficacy with current treatments, both of which contribute to the low prescription rate and limited widespread use.

– What are the main safety concerns that lead to significant challenges in gaining drug approval in obesity?
– Why is sustainable weight loss difficult to achieve, and what is the implication for future drug development?
Analysis reveals a high level of innovation and diversity in the pipeline, with 75 first-in-class programs identified to act on 60 unique molecular targets.
– What is the dominant target family across these first-in-class pipeline products?
– How well do they align with the underlying signaling pathways governing the central and peripheral regulation of food intake, and energy expenditure?

Some first-in-class targets are deemed more likely to be developed into marketable treatments than others, having demonstrated substantial body weight reduction in Pre-clinical studies and addressing multiple mechanisms underpinning the development of obesity.
– What is the scientific rationale behind these targets? How are they likely to surpass existing treatment?
– Apart from body weight change, what other parameters are commonly used to measure the effect of investigational therapies?

Deals involving first-in-class obesity products are more likely to be made in earlier stages of development than non-first-in-class deals, supported by industry-wide analysis.
– What is the dominant molecular target in the obesity deals landscape?
– What are the promising first-in-class products still available for future licensing?

Browse “Pharmaceuticals & Healthcare” Related Research Reports @
http://www.hexareports.com/category/pharmaceuticals-and-healthcare-market

Reasons to buy

This report will allow you to –

– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the available treatment options and their limitations in terms of safety and efficacy.
– Visualize the composition of the obesity market to highlight the current unmet needs in order to gain a competitive understanding of the key opportunities.
– Analyze the obesity pipeline and stratify by stage of development, molecule type, and molecular target; the diversity of molecular targets in the pipeline is extremely encouraging as obesity is characterized by the complex interplay between central and peripheral mechanisms.
– Assess the therapeutic potential of first-in-class targets using a proprietary matrix that assesses and ranks first-in-class products according to clinical potential.
– Target the most promising and innovative obesity products for early-stage investment by analyzing trends in licensing and co-development deals and accessing a curated list of first-in-class therapies potentially open to deal-making opportunities.

Request a Sample copy of this Report @
http://www.hexareports.com/sample/50925

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexareports.com/report/frontier-pharma-obesity-identifying-and-commercializing-first-in-class-innovation/details

Contact Info:
Name: Ryan Shaw
Organization: Hexa Reports
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/frontier-pharma-obesity-identifying-and-commercializing-first-in-class-innovation-research-report-by-hexa-reports/121220

Release ID: 121220

Latest Research on “Autoimmune Disease Diagnostics Market”. The rising prevalence of autoimmune diseases and consequent increase in healthcare expenditure globally are the major factors driving the Autoimmune Disease Diagnostics Market.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Moreover, the favorable government initiatives in various countries are also a factor leading to the growth of global autoimmune disease diagnostics market. As stated by NIH, autoimmune disease is one of the top ten causes of women deaths. The rapidly rising demand for autoimmune disease diagnosis is a direct consequence of increasing incidences of autoimmune diseases all over the world. Various laboratories have moved toward installation of equipments which are able to conduct various tests simultaneously and provide fast results.

The slow turnaround time of conventional autoimmune disease diagnostic procedures has encouraged various laboratories to move towards automation. The active awareness campaigns aimed to increase the awareness level regarding the diagnostics of diseases is the factor expected to further fuel the global autoimmune disease diagnostics market over the forecast period.

Browse Detail Report with TOC @
http://www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-industry/

The autoimmune disease diagnostics market on the basis of product is segmented into localized and systemic disease diagnostics. As of 2013, the local disease diagnostics attributed the largest share in the market owing to the relatively higher patient awareness level and the presence of huge procedure volumes. In localized autoimmune disease segment, there are huge unmet needs of the patients for various diseases such as type 1 diabetes. This factor is expected to drive the localized autoimmune disease diagnostics market over the forecast period.

The systemic autoimmune disease diagnostics segment include diagnosis of diseases such as lupus erythematosus (SLE), Ankylosing Spondylitis and rheumatoid. The rheumatoid segment attributes the largest share in the market owing to its most commonly usage in the diagnosis of autoimmune systemic inflammatory diseases. The entanglement of expensive organ assessment test in the rheumatoid disease is also a factor driving the systemic autoimmune rheumatoid disease diagnostics market. The innovation in products such as diagnosis based on drugs and presence of volume of tests at a large level are the factors expected to further drive this segment.

Browse Clinical Diagnostics Related Reports

Allergy Diagnostics And Therapeutics Market @
http://www.hexaresearch.com/research-report/allergy-diagnostic-market/

Glucose Biosensors Market @
http://www.hexaresearch.com/research-report/glucose-biosensors-market/

The global autoimmune disease diagnostics market on the basis of regions is segmented into North America, Europe, Asia Pacific and RoW. As of 2013, North America covered the largest share in the autoimmune disease diagnostics market in terms of revenue. The existence of favorable government initiatives such as Patient protection Act and Affordable Care Act and enlightened healthcare infrastructure are some other factors driving the market in this region. According to NIH, North America is accounted for the largest annual expenditure in autoimmune disease diagnostics market.

The rapidly increasing per capita expenditure on healthcare is the factor expected to further fuel the growth of this region. Europe is accounted for the second largest market as of 2013. The technological advances in autoimmune disease diagnosis such as novel biomarkers and potable diagnostic equipments and increasing incidences of autoimmune diseases are the key factors for the growth of autoimmune disease diagnostics market in this region. The factor expected for the further growth of this region is the huge untapped opportunities mainly in the Eastern Europe.

The rivalry levels for the Industry are expected to be moderately high over the forecast period owing to the consolidated nature of the market. This consolidated nature of the market has lead to the high presence of mergers and acquisitions in the autoimmune disease diagnostics market. Manufacturers are facing price based competition and they are under continuous pressure to bring innovation in the products. Some of the key players in the global autoimmune disease diagnostics market include Quest Diagnostics, Bio Rad, Hemagen Diagnostics, Crescendo Bioscience, bioMeriux SA, Abott Diagnostics and Roche Diagnostics. These players are constantly creating various competitive strategies such as collaborations, expansions and acquisitions to keep a strong foothold in the global autoimmune disease diagnostics market.

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/autoimmune-disease-diagnostics-market-is-forecasted-globally-to-reach-usd-14-17-billion-by-2020-hexa-research/121211

Release ID: 121211

Catheters Market is segmented on the basis of types into urology, cardiovascular, neurovascular, intravenous and specialty catheters. As per the recent report published by WHO, by 2030, 25 million people will die due to prevalence of cardiovascular disease.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Catheters market is expected to grow over the forecast period owing to the increasing prevalence of cardiovascular diseases and growing demand for minimally invasive medical procedures. The other growth drivers of this market are growing incidences of lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing population and awareness. These factors are expected to drive the market over the forecast period. For the purpose of conducting therapeutic and diagnostic treatment, flexible and hollow tubes are inserted into the body, which are referred as catheters. As per the recent report published by WHO, by 2030, 25 million people will die due to prevalence of cardiovascular disease.

Cardiovascular disease includes hypertensive heart disease, stroke, ischemic heart disease (IHD), aortic aneurysms, cardiomyopathy, rheumatic heart disease (RHD), congenital heart disease, atrial fibrillation, peripheral artery disease (PAD) and endocarditis. Minimally invasive surgeries are now more preferred than normal surgeries, as it has many advantages attached to it, such as shorter duration of stay at hospital, shorter recovery duration, less risk of bleeding and infection, and scars length is short. Quick procedure duration and faster patient recovery time are two important factors towards the rising demand of medical procedures. Over the forecast period, growing demand of minimally invasive procedures in the emerging countries like China and India is expected to fuel the future growth of this market. Over the upcoming forecast period, catheter market is expected to grow at a CAGR of 9.7%. In 2013, the market was valued at $ 24,380.3 million.

Access Detail Report with TOC @ http://www.hexaresearch.com/research-report/catheters-industry/

Product Insights

Catheters market is segmented on the basis of types into urology, cardiovascular, neurovascular, intravenous and specialty catheters. Among these, cardiovascular catheters held the largest market share in 2013 due to high incidences of cardiovascular diseases, increasing patient awareness and availability of high unmet medical demand in this segment. In 2013, revenue share of this market was approximately 40.0%. Further, due to adaptation towards minimally invasive interventional cardiology procedures and introduction of newly developed product i.e. bio-absorbable stents, has increased demand of these catheters, and the market is expected to grow nearby to CAGR of 16% over the upcoming five years.

Market penetration rate will significantly elevate, as bio-absorbable stents are at low re-stenosis rates. Bio-absorbable stents are used for removing blockage or expand the vessel by inserting a tube or device into the blood vessel. Advantage of bio-absorbable stents is that it can absorb or dissolved in the body after sometime of surgery, as compared to traditional stents. In terms of revenue, catheters are following stents, as it holds 10.0% market stake due to the increasing demand for angiography catheters. Heart related disorders such as blood vessel irregularities, congenital heart defects and atherosclerosis are diagnosed with the help of angiography catheters. A small incision is made in femoral artery, through which catheter is inserted and then moved to actual sire.

Request a Sample copy of this Report @ http://www.hexaresearch.com/sample/31

Regional Insights

Geographically, the catheters market is studied by segmenting the market into North America, Europe, Asia Pacific and RoW. North America is dominating the whole market due to high per capita healthcare expenditure, sophisticated healthcare infrastructure, rising disposable income, various government or NGO’s initiatives, and increasing geriatric population. In 2013, North America generated over 37% of revenue. The growing economies in Asia Pacific such as India and China region are expected to witness lucrative growth during the forecast period due to the rising healthcare expenditure, and awareness about the catheters. Asia Pacific region is expected to grow at a CAGR of 13.5% over the forecast period.

Competitive Insights

The major market players in the Catheters market are Abbott Laboratories, Boston Scientific Corporation, Arrow International, Coloplast, Medtronic Inc., and Johnson & Johnson.

Browse More Reports on “Pharmaceuticals” @
http://www.hexaresearch.com/research-category/pharmaceuticals-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/catheters-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/catheters-market-is-expected-to-grow-at-a-cagr-of-9-7-from-2014-to-2020-hexa-research/121204

Release ID: 121204

Hexa Research added “Tea Polyphenols Market” report to their database. Tea Polyphenols are extracted from the same plant called Camellia Sinensis but processed differently in order to achieve required level of oxidation.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Industry Insights

Tea polyphenols market has been witnessing strong growth over the past few years on account of increasing demand from food and beverage industry, and the trend is expected to continue over the forecast period. Rising purchasing parity of consumers coupled with changing life style has increased the consumption of tea polyphenols over the last few years and it is anticipated to fuel the market growth in near future.

Growing health concerns over the last few years resulted in increasing demand for green tea and other nutraceutical products, which in turn expected to drive tea polyphenols market over the forecast period. Innovation in functional beverage’s industry owing to rising demand for healthy drinks is anticipated to drive the market growth over the next six years. Growing dietary supplements demand coupled with increasing awareness towards the health benefits from tea polyphenols consumption is anticipated to complement the market growth over the foreseeable period. Tea polyphenols have ability to cure health problems like obesity, heart diseases, cancer and diabetes. These advantageous factors are likely to augment the market growth in near future.

Access Detail Report with TOC @ http://www.hexaresearch.com/research-report/tea-polyphenols-industry/

Product Insights

All tea polyphenols are extracted from the same plant called Camellia Sinensis but processed differently in order to achieve required level of oxidation. Green tea polyphenols are zero oxidized leaves, black tea polyphenols are completely oxidized tea leaves, whereas oolong tea polyphenols are semi oxidized. Green tea polyphenols market is the most dominant product segment followed by oolong and black tea polyphenols.

Increasing obesity and cancer patient during the last few years has been driving green tea polyphenols market at a good pace, and the trend is expected to continue over the forecast period. Oolong tea polyphenols are consumed mainly to avoid diabetes which is the most threatened disease over the last five years. Increasing diabetes patients across the globe is anticipated to increase the consumption of oolong tea polyphenols which in turn expected to drive the market over the forecast period.

Application Insights

Functional foods and beverages was the largest and fastest growing application segment for tea polyphenols market over the recent past, and the trend is expected to continue over the forecast period. Increasing demand for functional foods and health drinks has been driving tea polyphenols market in this sector. In addition, growing health concerns and rising disposable income of consumers motivating them to spend more on health beneficial products which is expected to boost the market demand over the forecast period. Dietary food supplements industry is the second major market for tea polyphenols owing to increasing health problems like obesity, diabetes and heart diseases.

Request a Sample Copy of This Report @ http://www.hexaresearch.com/sample/209

Regional Insights

Asia Pacific was the largest market for tea polyphenols over the recent past in terms of production and consumption. Owing increasing population in countries such as China and India, the demand for tea polyphenols is expected to grow at a good pace over the forecast period. Increasing disposable income and changing life styles of consumers in this region coupled with growing concern towards health is also a key driving factor for tea polyphenols market. North America is expected to witness significant growth on account of increasing demand from foods & beverages industry in this region. However, Europe has been witnessing sluggish growth over the past few years due to some side effects of green tea polyphenols consumption.

Competitive Insights

Tea polyphenols market is highly concentrated with less number of manufacturing companies leading the global market of tea polyphenols over the last decade. Scope for new entrants in tea polyphenols market is very less, so there is a huge scope for existing players to increase their capacity levels to fulfill the increasing demand across the globe over the forecast period. Additionally, improving R&D activities by major key players to use tea polyphenols in medical sector is anticipated to open new opportunities to this market over the next six years. Some major players in this market include Ajinomoto OmniChem, Amax NutraSource Inc., Indena Spa and Guilin Layn Natural Ingredients Inc.

Browse Reports On “Nutraceuticals & Functional Foods” @
http://www.hexaresearch.com/research-category/nutraceuticals-and-functional-foods-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For More Detail Report on “Global Tea Polyphenols Market” Visit @
http://www.hexaresearch.com/research-report/tea-polyphenols-industry/

For more information, please visit http://www.hexaresearch.com/research-report/tea-polyphenols-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/tea-polyphenols-market-is-estimated-to-reach-a-value-of-usd-367-7-million-by-2020-globally-by-hexa-research/121196

Release ID: 121196

Global lactic acid is expected to reach 1,960.1 kilo tons by 2020 and Global Poly Lactic Acid (PLA) is expected to reach 1,205.3 kilo tons by 2020, growing at a CAGR of 18.8% from 2014 to 2020.

Felton, United States – June 27, 2016 /MarketersMedia/ —

Increasing lactic acid demand for manufacturing poly lactic acid (PLA) is expected to fuel the global lactic acid market growth over the next five years. Lactic acid has gained significant importance recently. It is a colorless syrup liquid soluble in alcohol and water. The product is manufactured by fermentation of carbohydrates in excess calcium carbonate presence. Raw materials for lactic acid manufacturing process include sugar beet, corn, sugarcane and tapioca. Asia has the abundant quantity of such raw materials owing to huge production of carbohydrates particularly sugarcane. This is expected to help lactic acid producers to cut down their manufacturing cost due to low raw material prices as compared to other regions.

Growing awareness regarding eco-friendly products and demand for green products in packaging industries is anticipated to boost the global PLA market growth over the next five years. PLA is compostable and biodegradable as derived from natural sources, which is anticipated to drive the global PLA market over the next five years. Volatile crude oil prices are expected to reduce reliance on petrochemicals and are anticipated to foster the global PLA market growth. Shift towards bioplastics owing to changing consumer and industries preference is projected to witness significant growth over the foreseeable future.

Browse Detail Report with TOC @ http://www.hexaresearch.com/research-report/lactic-acid-and-poly-lactic-acid-industry/

PLA faces drawbacks due to less efficient performance as compared to other conventional plastics are expected to hinder the market. Another key challenge is vulnerability with rising temperature which is expected to limit its applications in several areas such as utility packaging. However, many key participants are investing in R&D to enhance the product’s heat resistant property which is projected to generate immense opportunities for the PLA market.

Industrial were the largest application segment accounting for over 45% of the total market in 2013. This segment is expected to dominant the market and fastest growing segment over the forecast period owing to increasing usage in lactate solvents and biodegradable polymers. Lactic acid is also used in manufacturing personal care products such as anti-wrinkle, anti-acne, skin lightening and anti-aging. Growing personal care products demand is also anticipated to fuel the global lactic acid market over the next five years. Packaging was the dominant application market accounting for over 60% of the total demand in 2013. PLA manufactured bottles comprise properties such as disposable, durable, glossy and transparency, which gained importance in the market in the recent past. The product is compostable and does not emit toxic gases during decomposition. This is expected to gain more applications in the market. Textile application market is anticipated to be the fastest growing segment over the next five years.

Browse “Renewable Chemicals” Related Research Reports @
http://www.hexaresearch.com/research-category/renewable-chemicals-industry/

North America was the largest lactic acid market accounting for over 35% of the global demand and is expected to be the dominant market in the near future. Growing demand for the product in the application segment market is the key factor for the market growth. Asia Pacific is anticipated to be the fastest growing lactic acid market over the forecast period owing to increasing demand for biodegradable polymers and abundant availability of raw materials. Europe dominated the PLA market accounting for over 37% of the total demand in 2013 and is expected to remain dominant in the near future.

Growing demand in packaging industries and favorable regulatory scenario for bio-based products are the driving forces for the PLA market growth over the next five years.The global market is concentrated in nature with limited major players include BASF, Galactic, Synbra, Purac, NatureWorks LLC and Pyramid Bioplastics. Capacity expansion and product innovations are the major implemented strategies by the participants to gain the market share. Favorable government scenario regarding bio-based products has supported them to diversify the business. Technology development to in process to build a high heat resistant PLA is expected to create ample opportunities in the market by replacing conventional plastics.

Visit our Website @ http://www.hexaresearch.com/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/lactic-acid-and-poly-lactic-acid-industry/

Contact Info:
Name: Ryan Shaw
Organization: Hexa Research
Address: elton Office Plaza 6265 Highway 9 Felton, California 95018
Phone: +1-800-489-3075

Source: http://marketersmedia.com/lactic-acid-and-poly-lactic-acid-pla-market-is-expected-to-drive-the-chemical-market-by-2020-hexa-research/121184

Release ID: 121184